| No. of Patients (n = 42) | % |
---|---|---|
Median Age (years) | 57.5 | Â |
   Range | 33-82 |  |
HER2 status | Â | Â |
   Negative | 27 | 64.3 |
   Positive | 15 | 35.7 |
Metastatic disease | Â | Â |
   Bone | 21/42 | 50 |
   Liver | 17/42 | 40.5 |
   Skin | 16/42 | 38.1 |
   Lung | 12/42 | 28.6 |
   CNS†| 5/42 | 11.9 |
   Lymph nodes | 4/42 | 9.5 |
   Bone marrow | 1/42 | 2.4 |
Malignant pleural effusion | 4/42 | 9.5 |
Malignant ascites | 1/42 | 2.4 |
Line of treatment | Â | Â |
   2nd | 21 | 50 |
   3rd | 15 | 35.7 |
   4th | 4 | 9.5 |
   5th | 2 | 4.8 |